Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Companies  >  All News

News : Companies

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors

Research and Markets: Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Pipeline Review, H1 2015 - 24 Companies & 15 Drug Profiles

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/09/2015 | 03:48pm CET

Research and Markets (http://www.researchandmarkets.com/research/g4d563/ankylosing) has announced the addition of the "Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Ankylosing Spondylitis (Bekhterev's Disease), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Ankylosing Spondylitis (Bekhterev's Disease) and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Involved in Therapeutics Development

  • Amgen Inc.
  • Avesthagen Limited
  • BIOCAD
  • Biocon Limited
  • Boehringer Ingelheim GmbH
  • Celgene Corporation
  • Celltrion, Inc.
  • Covagen AG
  • Epirus Biopharmaceuticals, Inc.
  • Genor BioPharma Co., Ltd.
  • Inbiopro Solutions Pvt. Ltd.
  • Innovent Biologics, Inc.
  • Johnson & Johnson
  • Lupin Limited
  • Mabion SA
  • Momenta Pharmaceuticals, Inc.
  • Novartis AG
  • Oncobiologics, Inc.
  • Panacea Biotec Limited
  • Pfizer Inc.
  • Protalix BioTherapeutics, Inc.
  • Sandoz International GmbH
  • Shanghai Pharmaceutical Co., Ltd.
  • Therapeutic Proteins International, LLC

Drug Profiles

  • adalimumab biosimilar
  • apremilast
  • BI-655066
  • COVA-322
  • etanercept biosimilar
  • golimumab
  • golimumab biosimilar
  • IBI-303
  • IBPM-004AM
  • IBPM-005IX
  • infliximab biosimilar
  • INV-17
  • secukinumab
  • thalidomide
  • tofacitinib

For more information visit http://www.researchandmarkets.com/research/g4d563/ankylosing


© Business Wire 2015
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news "Companies"
08:31pUPCOMING DEADLINE ALERT : The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Honeywell International Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
GL
08:31pPEDIAPHARM : Medexus Announces New Chief Executive Officer, Chair of the Board of Directors, Other Organizational Updates and Equity Incentive Grants
AQ
08:31pINVENTHELP : Inventor Develops Fun Variation on Dart-Style Games (KOC-981)
PR
08:31pTractor Supply Company Announces Goal to Reduce Carbon Emissions from Facilities by 25 Percent
GL
08:31pTINTRI BY DDN : Releases Tintri TGC 4.0 – The Next Generation of Simplified Storage Management
BU
08:30pNEWMARK : Knight Frank Handles Sale of Anaheim Office Building to Leading Healthcare Provider AltaMed Health Services
PU
08:29pCARLYLE LP : nearing deal to buy StandardAero for more than $5 billion - sources
RE
08:28pCARLYLE NEARING DEAL TO BUY STANDARDAERO FOR MORE THAN $5 BILLION : sources
RE
08:28pFANCAMP EXPLORATION : - Grassroots Gold Exploration Update
AQ
08:25pRANDGOLD RESOURCES : Declaration of Interim Dividend and Issuance of Shares
PU
Latest news "Companies"
Advertisement